Literature DB >> 7751374

Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.

B Jahn1, E Martin, A Stueben, S Bhakdi.   

Abstract

We describe a simple microtiter method for determining the susceptibility of Candida albicans and hyphal forms of Aspergillus fumigatus against antifungal agents. The assay measures mitochondrial respiration by determining reduction of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) to formazan, a process that is enhanced in the presence of menadione. C. albicans or conidial suspensions of A. fumigatus are seeded into microtiter plates. Hyphal outgrowth of Aspergillus spp. was achieved by a 12 to 14-h culture at 30 degrees C. Antifungal agents (amphotericin B, fluconazole, itraconazole) were added to the cultures for 24 h. Thereafter, incubations were continued for 3 h in the presence of MTT plus 0.1 mM menadione. Formazan formation was quantified photometrically after extraction of the formazan with acid isopropanol. Well-defined dose-response curves reflecting impairment of mitochondrial function by the antifungal agents were obtained. With C. albicans, the results correlated excellently with the MIC determinations performed according to the standard macrodilution procedure. In confirmation of a recent report, it was found that fluconazole was unable to exert its fungistatic action on a sensitive C. albicans strain in the presence of serum. The presented method can easily be integrated in the standard repertoire of a diagnostic microbiology laboratory and should prove useful as a means to assess the antifungal action of various agents on yeasts and filamentous fungi in the presence and absence of serum proteins or body fluids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751374      PMCID: PMC228010          DOI: 10.1128/jcm.33.3.661-667.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

Review 1.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

2.  Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

Authors:  S Redding; J Smith; G Farinacci; M Rinaldi; A Fothergill; J Rhine-Chalberg; M Pfaller
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

3.  Failure of fluconazole therapy for sternal osteomyelitis due to Candida albicans.

Authors:  M Dan; I Priel
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.

Authors:  J H Rex; J E Bennett; J I Gallin; H L Malech; D A Melnick
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

6.  Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.

Authors:  J H Baker; H C Goodpasture; H R Kuhns; M G Rinaldi
Journal:  Arch Pathol Lab Med       Date:  1989-11       Impact factor: 5.534

7.  A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT.

Authors:  S M Levitz; R D Diamond
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

8.  Amphotericin B-resistant yeast infection in severely immunocompromised patients.

Authors:  W G Powderly; G S Kobayashi; G P Herzig; G Medoff
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

9.  Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients.

Authors:  W Mills; R Chopra; D C Linch; A H Goldstone
Journal:  Br J Haematol       Date:  1994-04       Impact factor: 6.998

10.  Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.

Authors:  M A Pfaller; A L Barry
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

View more
  31 in total

1.  Rapid flow cytometric susceptibility testing of Candida albicans.

Authors:  R Ramani; A Ramani; S J Wong
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole.

Authors:  A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori.

Authors:  Kwang H Lee; Dong G Lee; Yoonkyung Park; Dong-Il Kang; Song Y Shin; Kyung-Soo Hahm; Yangmee Kim
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

4.  Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; P J Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Colorimetric assay for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  An essential complementary role of NF-kappaB pathway to microbicidal oxidants in Drosophila gut immunity.

Authors:  Ji-Hwan Ryu; Eun-Mi Ha; Chun-Taek Oh; Jae-Hong Seol; Paul T Brey; Ingnyol Jin; Dong Gun Lee; Jaesang Kim; Daekee Lee; Won-Jae Lee
Journal:  EMBO J       Date:  2006-07-20       Impact factor: 11.598

7.  Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; S Nangia; J H Rex
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.

Authors:  A Marcil; D Harcus; D Y Thomas; M Whiteway
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

9.  Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.

Authors:  B Jahn; A Stüben; S Bhakdi
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Authors:  E Herreros; C M Martinez; M J Almela; M S Marriott; F G De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.